News tagged with memantine
Memantine is the first in a novel class of Alzheimer's disease medications acting on the glutamatergic system by blocking NMDA glutamate receptors. It was first synthesized by Eli Lilly and Company in 1968. Memantine is marketed under the brands Axura and Akatinol by Merz, Namenda by Forest, Ebixa and Abixa by Lundbeck and Memox by Unipharm. Despite years of research, whether memantine has any effect in mild to moderate Alzheimer's disease is unknown.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
A new drug may improve memory problems in people with moderate Alzheimer's disease, according to a phase IIa study released today that will be presented at the American Academy of Neurology's 65th Annual Meeting in San Diego, ...
Alzheimer's disease & dementia Mar 11, 2013 | 4.5 / 5 (2) | 0
The dementia drug donepezil (Aricept), already widely used to treat mild to moderate Alzheimer's disease, can also help in moderate to severe patients, according to a report funded by the UK Medical Research Council (MRC) ...
Alzheimer's disease & dementia Mar 07, 2012 | 5 / 5 (1) | 0 |
Alzheimer's disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it's doing any good, a new study says.
Alzheimer's disease & dementia Mar 08, 2012 | 5 / 5 (1) | 0
Researchers at the University of Colorado School of Medicine have found a drug that boosts memory function in those with Down syndrome, a major milestone in the treatment of this genetic disorder that could significantly ...
Psychology & Psychiatry Jul 17, 2012 | 5 / 5 (1) | 0 |